NextCell Pharma AB (NXTCL.ST)
SEK 2.42
(-13.57%)
SEK 2.42
(-13.57%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -41.95 Million SEK | -5.4% |
| 2023 | -39.81 Million SEK | -16.8% |
| 2022 | -34.08 Million SEK | -38.76% |
| 2021 | -24.56 Million SEK | -38.86% |
| 2020 | -17.68 Million SEK | 17.56% |
| 2019 | -21.45 Million SEK | -52.92% |
| 2018 | -14.03 Million SEK | -5.94% |
| 2017 | -13.24 Million SEK | -16.05% |
| 2016 | -11.41 Million SEK | -10.92% |
| 2015 | -10.28 Million SEK | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q4 | -13.24 Million SEK | -50.19% |
| 2024 Q1 | -9.79 Million SEK | -14.32% |
| 2024 Q2 | -10.09 Million SEK | -3.03% |
| 2024 Q3 | -8.82 Million SEK | 12.6% |
| 2023 Q3 | -10.91 Million SEK | 1.94% |
| 2023 Q1 | -8.75 Million SEK | -4.01% |
| 2023 FY | -39.81 Million SEK | -16.8% |
| 2023 Q4 | -8.56 Million SEK | 21.5% |
| 2023 Q2 | -11.13 Million SEK | -27.09% |
| 2022 Q3 | -9.2 Million SEK | 8.82% |
| 2022 Q1 | -6.47 Million SEK | -44.53% |
| 2022 Q2 | -10.09 Million SEK | -55.91% |
| 2022 Q4 | -8.42 Million SEK | 8.48% |
| 2022 FY | -34.08 Million SEK | -38.76% |
| 2021 Q3 | -6.45 Million SEK | 20.75% |
| 2021 FY | -24.56 Million SEK | -38.86% |
| 2021 Q1 | -5.47 Million SEK | -12.22% |
| 2021 Q2 | -8.14 Million SEK | -48.87% |
| 2021 Q4 | -4.47 Million SEK | 30.65% |
| 2020 Q4 | -4.87 Million SEK | -0.91% |
| 2020 Q3 | -4.83 Million SEK | -14.31% |
| 2020 Q2 | -4.22 Million SEK | -12.58% |
| 2020 Q1 | -3.75 Million SEK | 52.9% |
| 2020 FY | -17.68 Million SEK | 17.56% |
| 2019 Q1 | -5.44 Million SEK | -58.98% |
| 2019 FY | -21.45 Million SEK | -52.92% |
| 2019 Q3 | -4.6 Million SEK | -29.5% |
| 2019 Q4 | -7.97 Million SEK | -73.33% |
| 2019 Q2 | -3.55 Million SEK | 34.71% |
| 2018 Q4 | -3.42 Million SEK | -10.91% |
| 2018 FY | -14.03 Million SEK | -5.94% |
| 2018 Q1 | -3.21 Million SEK | 32.65% |
| 2018 Q2 | -4.31 Million SEK | -34.34% |
| 2018 Q3 | -3.08 Million SEK | 28.46% |
| 2017 Q4 | -4.76 Million SEK | -31.91% |
| 2017 Q1 | -2.46 Million SEK | -4.62% |
| 2017 Q2 | -2.39 Million SEK | 2.6% |
| 2017 Q3 | -3.61 Million SEK | -50.61% |
| 2017 FY | -13.24 Million SEK | -16.05% |
| 2016 Q1 | -3 Million SEK | 0.0% |
| 2016 FY | -11.41 Million SEK | -10.92% |
| 2016 Q4 | -2.35 Million SEK | 22.83% |
| 2016 Q3 | -3.05 Million SEK | -1.59% |
| 2016 Q2 | -3 Million SEK | 0.0% |
| 2015 FY | -10.28 Million SEK | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Alligator Bioscience AB (publ) | -248.58 Million SEK | 83.121% |
| Ziccum AB (publ) | -21.41 Million SEK | -95.964% |
| Modus Therapeutics Holding AB (publ) | -17.89 Million SEK | -134.452% |
| BioArctic AB (publ) | 229.24 Million SEK | 118.303% |
| Sprint Bioscience AB (publ) | -438 Thousand SEK | -9479.867% |
| Mendus AB (publ) | -101.61 Million SEK | 58.709% |
| Genovis AB (publ.) | 61.5 Million SEK | 168.227% |
| Intervacc AB (publ) | -102.85 Million SEK | 59.204% |
| QuiaPEG Pharmaceuticals Holding AB (publ) | -16.52 Million SEK | -153.948% |
| Active Biotech AB (publ) | -45.8 Million SEK | 8.385% |
| Magle Chemoswed Holding AB (publ) | 12.16 Million SEK | 444.809% |
| Bio-Works Technologies AB (publ) | -56.82 Million SEK | 26.154% |
| Aptahem AB (publ) | -11.11 Million SEK | -277.579% |
| Vicore Pharma Holding AB (publ) | -310.94 Million SEK | 86.506% |
| Kancera AB (publ) | -64.88 Million SEK | 35.336% |
| Infant Bacterial Therapeutics AB (publ) | -123.06 Million SEK | 65.905% |
| Fluicell AB (publ) | -26.55 Million SEK | -58.017% |
| Saniona AB (publ) | -95.81 Million SEK | 56.205% |
| Lipigon Pharmaceuticals AB (publ) | -12.12 Million SEK | -245.975% |
| Biovica International AB (publ) | -124.82 Million SEK | 66.385% |
| Spago Nanomedical AB (publ) | -42.22 Million SEK | 0.623% |
| AcouSort AB (publ) | -17.08 Million SEK | -145.537% |
| Xintela AB (publ) | -54.08 Million SEK | 22.416% |
| Abliva AB (publ) | -95.5 Million SEK | 56.067% |
| Egetis Therapeutics AB (publ) | -326.9 Million SEK | 87.164% |
| Karolinska Development AB (publ) | 5.38 Million SEK | 879.053% |
| OncoZenge AB (publ) | -15.9 Million SEK | -163.865% |
| Amniotics AB (publ) | -30.87 Million SEK | -35.924% |
| 2cureX AB (publ) | -32.51 Million SEK | -29.036% |
| CombiGene AB (publ) | -35.66 Million SEK | -17.649% |
| Asarina Pharma AB (publ) | -12.82 Million SEK | -227.096% |
| Calliditas Therapeutics AB (publ) | -466.18 Million SEK | 90.999% |
| Camurus AB (publ) | 431.44 Million SEK | 109.725% |
| Corline Biomedical AB | -1.8 Million SEK | -2219.503% |
| IRLAB Therapeutics AB (publ) | -177.83 Million SEK | 76.406% |
| Isofol Medical AB (publ) | -37.07 Million SEK | -13.188% |
| I-Tech AB | 20.2 Million SEK | 307.691% |
| Hansa Biopharma AB (publ) | -831.72 Million SEK | 94.955% |
| Cyxone AB (publ) | -22.98 Million SEK | -82.521% |
| ExpreS2ion Biotech Holding AB (publ) | -91.4 Million SEK | 54.093% |
| Biosergen AB | -27.03 Million SEK | -55.194% |
| Cantargia AB (publ) | -280.02 Million SEK | 85.016% |
| Xspray Pharma AB (publ) | -179.66 Million SEK | 76.646% |
| Elicera Therapeutics AB (publ) | -16.39 Million SEK | -155.884% |
| Nanologica AB (publ) | -75.15 Million SEK | 44.17% |
| SynAct Pharma AB | -215.81 Million SEK | 80.557% |
| Annexin Pharmaceuticals AB (publ) | -44.05 Million SEK | 4.754% |
| Stayble Therapeutics AB (publ) | -23.73 Million SEK | -76.77% |
| LIDDS AB (publ) | -40.2 Million SEK | -4.362% |
| Lipum AB (publ) | -37.17 Million SEK | -12.862% |
| BioInvent International AB (publ) | -330.3 Million SEK | 87.297% |
| Alzinova AB (publ) | -16.48 Million SEK | -154.611% |
| Oncopeptides AB (publ) | -249.11 Million SEK | 83.156% |
| Pila Pharma AB (publ) | -9.93 Million SEK | -322.556% |
| Guard Therapeutics International AB (publ) | -113.32 Million SEK | 62.973% |
| Scandinavian ChemoTech AB (publ) | -21.09 Million SEK | -98.947% |
| Simris Alg AB (publ) | -37.3 Million SEK | -12.478% |
| Diamyd Medical AB (publ) | -151.85 Million SEK | 72.368% |
| Xbrane Biopharma AB (publ) | -388.17 Million SEK | 89.19% |
| Ascelia Pharma AB (publ) | -109.28 Million SEK | 61.606% |
| Diagonal Bio AB (publ) | -11.67 Million SEK | -259.307% |